Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $62.06 ($557K) on 2015-07-01, disclosed to the SEC on 2015-07-02.
Scheduled sale ($557k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.04 | 3,309 | $202K | 36.3% |
| 2 | $62.06 | 3,177 | $197K | 35.4% |
| 3 | $62.82 | 2,514 | $158K | 28.3% |
| Total | $61.90 avg | 9,000 | $557K | 100% |
| Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |